In DepthU.S. RESEARCH POLICY

Trump officials move to limit human fetal tissue research

See allHide authors and affiliations

Science  14 Dec 2018:
Vol. 362, Issue 6420, pp. 1223-1224
DOI: 10.1126/science.362.6420.1223

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

U.S. President Donald Trump's administration is taking steps to limit the use of human fetal tissue from elective abortions in biomedical research. Last week, administration officials told researchers at one California university that their contract work involving fetal tissue would not receive the usual 1-year extension. And Science has learned that this past September, officials quietly ordered scientists employed by the U.S. National Institutes of Health (NIH) to stop acquiring new human fetal tissue for experiments. Both moves come as the Trump administration has launched a review of all federally funded research with fetal tissue, which is used to study several diseases. The actions have prompted fears that NIH-funded university scientists who work with fetal tissue could face a broader clampdown.